The evolving landscape of data integrity in good clinical practice
In recent years, regulatory agencies have placed renewed emphasis on data integrity in clinical...
Subjectivity in risk: catalyzing catastrophe or creativity?
In the highly regulated world of pharmaceuticals and life sciences, risk isn’t just a numerical...
AI meets gxp: model cards for trust, transparency and compliance
Artificial intelligence is shaking up the pharmaceutical industry, delivering efficiencies in...